Literature DB >> 27666627

Cloud-processed 4D CMR flow imaging for pulmonary flow quantification.

Raluca G Chelu1, Kevin W Wanambiro2, Albert Hsiao3, Laurens E Swart4, Teun Voogd5, Allard T van den Hoven6, Matthijs van Kranenburg6, Adriaan Coenen4, Sara Boccalini7, Piotr A Wielopolski5, Mika W Vogel8, Gabriel P Krestin5, Shreyas S Vasanawala9, Ricardo P J Budde4, Jolien W Roos-Hesselink6, Koen Nieman4.   

Abstract

OBJECTIVES: In this study, we evaluated a cloud-based platform for cardiac magnetic resonance (CMR) four-dimensional (4D) flow imaging, with fully integrated correction for eddy currents, Maxwell phase effects, and gradient field non-linearity, to quantify forward flow, regurgitation, and peak systolic velocity over the pulmonary artery.
METHODS: We prospectively recruited 52 adult patients during one-year period from July 2014. The 4D flow and planar (2D) phase-contrast (PC) were acquired during same scanning session, but 4D flow was scanned after injection of a gadolinium-based contrast agent. Eddy-currents were semi-automatically corrected using the web-based software. Flow over pulmonary valve was measured and the 4D flow values were compared against the 2D PC ones.
RESULTS: The mean forward flow was 92 (±30) ml/cycle measured with 4D flow and 86 (±29) ml/cycle measured with 2D PC, with a correlation of 0.82 and a mean difference of -6ml/cycle (-41-29). For the regurgitant fraction the correlation was 0.85 with a mean difference of -0.95% (-17-15). Mean peak systolic velocity measured with 4D flow was 92 (±49) cm/s and 108 (±56) cm/s with 2D PC, having a correlation of 0.93 and a mean difference of 16cm/s (-24-55).
CONCLUSION: 4D flow imaging post-processed with an integrated cloud-based application accurately quantifies pulmonary flow. However, it may underestimate the peak systolic velocity.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  4D CMR flow imaging; Eddy current correction; Flow visualization; Phase contrast; Pulmonary regurgitant fraction

Mesh:

Substances:

Year:  2016        PMID: 27666627     DOI: 10.1016/j.ejrad.2016.07.018

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  ELHnet: a convolutional neural network for classifying cochlear endolymphatic hydrops imaged with optical coherence tomography.

Authors:  George S Liu; Michael H Zhu; Jinkyung Kim; Patrick Raphael; Brian E Applegate; John S Oghalai
Journal:  Biomed Opt Express       Date:  2017-09-20       Impact factor: 3.732

Review 2.  Recent Advances and Trends in Pediatric Cardiac Imaging.

Authors:  Wadi Mawad; Luc L Mertens
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-21

Review 3.  Four-dimensional flow cardiovascular magnetic resonance in tetralogy of Fallot: a systematic review.

Authors:  Ayah Elsayed; Kathleen Gilbert; Miriam Scadeng; Brett R Cowan; Kuberan Pushparajah; Alistair A Young
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-20       Impact factor: 5.364

4.  Evaluation of atrial septal defects with 4D flow MRI-multilevel and inter-reader reproducibility for quantification of shunt severity.

Authors:  Raluca G Chelu; Michael Horowitz; Dominica Sucha; Isabella Kardys; Delphine Ingremeau; Shreyas Vasanawala; Koen Nieman; Jean-Francois Paul; Albert Hsiao
Journal:  MAGMA       Date:  2018-08-31       Impact factor: 2.310

Review 5.  MR Imaging in the 21st Century: Technical Innovation over the First Two Decades.

Authors:  Hiroyuki Kabasawa
Journal:  Magn Reson Med Sci       Date:  2021-04-16       Impact factor: 2.760

Review 6.  Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review.

Authors:  Miroslawa Gorecka; Malenka M Bissell; David M Higgins; Pankaj Garg; Sven Plein; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2022-08-22       Impact factor: 6.903

7.  Clinical use of 4D flow MRI for quantification of aortic regurgitation.

Authors:  Ana Alvarez; Vicente Martinez; Gonzalo Pizarro; Manuel Recio; Jose Ángel Cabrera
Journal:  Open Heart       Date:  2020-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.